Study of predictive factors for response to 177LU-PSMA in patients with metastatic castration-resistant prostate cancer
This study identified several clinical, biological, and <sup>68</sup>Ga-PSMA PET/CT-derived factors associated with early treatment discontinuation. Patients with poor overall health, aggressive or extensive disease, or low PSMA expression are at higher risk of treatment failure.
Authors
- Valérie Seegers (ORCID: https://orcid.org/0000-0001-6076-385X)
- Pierre-Alban Dufour
- Hugo Peslier
Institutions
- Institut de Cancérologie de l'Ouest (FR)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-03-17
- DOI
- https://doi.org/10.3389/fmed.2025.1538507
- Citations
- 2
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 3.04